Oxford Antibiotic Group

The Oxford Antibiotic Group is an innovative drug discovery and development company that brings together industrial drug development expertise with Oxford University’s excellence in Chemistry and Life Sciences.

The company’s management team has more than 20 years industrial experience in developing innovative therapies from natural compounds. The core expertise of OxAG is screening based compound optimization by medicinal chemistry.

The company has designed in-house platforms for chemical synthesis and analytics, deployed to a set of bioactive and pre-clinical test systems. For OCT, the Oxford Antibiotic Group works on the development of novel compounds based on cannabinoids, by using their innovative logi-biotic approach.